Ted Monohon - Chief Accounting Officer & VP at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Accounting Officer & VP
Stock Symbol
QNCX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ted Monohon since 7/7/2023

Holdings reported by Ted Monohon for Quince Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 27,440 $25.8 K $0.94 Mar 6, 2023 Direct
Employee Stock Option (right to buy) 110,000 Feb 1, 2023 Direct Common Stock

Transactions reported by Ted Monohon for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership